Mefloquine Export Market Intelligence: India's 75 Suppliers Shipping to 56 Countries — TransData Nexus 2026

Q: Who are the top mefloquine exporters from India?

The top mefloquine exporters from India are: 1. CIPLA LIMITED — $1.4M (57.3% market share); 2. KALINDI OVERSEAS — $116.7K (4.8% market share); 3. YASHICA PHARMACEUTICALS PRIVATE LIMITED — $83.0K (3.4% market share); 4. ARVINCARE — $51.1K (2.1% market share); 5. DEUTSCHE LABS INC. — $46.0K (1.9% market share). Together they account for 69.4% of India's total mefloquine export value.

Q: What is the total export value of mefloquine from India?

The total export value of mefloquine from India is $2.4M USD, recorded across 265 shipment transactions from 75 active exporters to 56 destination countries. The average shipment value is $9.2K.

Q: Which countries import mefloquine from India?

India exports mefloquine to 56 countries worldwide. The top importing countries are: CAMBODIA (49.2% share, $1.2M), BRAZIL (4.7% share, $114.1K), NEPAL (3.9% share, $95.2K), UGANDA (3.9% share, $94.6K), SINGAPORE (3.7% share, $90.5K). These five markets account for 65.3% of total export value.

Q: What is the HS code for mefloquine exports from India?

The primary HS code for mefloquine exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of mefloquine exports from India?

The average unit price for mefloquine exports from India is $9.62 USD per unit, with prices ranging from $0.01 to $551.15 depending on formulation, packaging, and order volume. The total market is valued at $2.4M across 265 shipments.

Q: Which ports handle mefloquine exports from India?

The primary ports for mefloquine exports from India are SAHAR AIR CARGO ACC (INBOM4) (40.4% of shipments), SAHAR AIR (22.3% of shipments), Bombay Air (7.5% of shipments), DELHI AIR (4.5% of shipments), Bombay Air Cargo (4.5% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of mefloquine?

India is one of the world's leading exporters of mefloquine due to its large base of 75 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports mefloquine to 56 countries, demonstrating 29% global market coverage.

Q: What certifications do Indian mefloquine exporters need?

Indian mefloquine exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import mefloquine from India?

There are 118 registered buyers importing mefloquine from India, spread across 56 countries. The repeat buyer rate is 48.3%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top mefloquine supplier from India?

CIPLA LIMITED is the leading mefloquine exporter from India with a market share of 57.3% and total export value of $1.4M across 11 shipments. The top 5 suppliers together control 69.4% of total export value.

Suresh Sormare

Mefloquine

India Pharmaceutical Trade Intelligence

$2.4M75 Suppliers56 CountriesHS 30049099

ExportsIndia → CAMBODIA49.2%India → BRAZIL4.7%

ImportsCANADA → India$96

#1 Supplier: CIPLA LIMITED

Mefloquine Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Mefloquine to the World

Between 2022 and 2026, India exported $2.4M worth of mefloquine across 265 verified shipments to 56 countries — covering 29% of world markets in the Antimalarial & Antiparasitic segment. The largest destination is CAMBODIA (49.2%). CIPLA LIMITED leads with a 57.3% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Mefloquine export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Mefloquine export data snapshot — $2.4M · 75 exporters · 56 countriesTransData Nexus · Indian Customs Data

Top Mefloquine Exporters from India

75 active exporters · Ranked by export value

View all 75 →

Top Mefloquine Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	CIPLA LIMITED	$1.4M	11	5	57.3%
2	KALINDI OVERSEAS

Top Countries Importing Mefloquine from India

56 destination markets · Ranked by import value

All 56 countries →

Top Countries Importing Mefloquine from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	CAMBODIA	$1.2M	49.2%
2	BRAZIL	$114.1K	4.7%
3	NEPAL	$95.2K	3.9%
4	UGANDA	$94.6K	3.9%
5	SINGAPORE	$90.5K	3.7%
6	PERU	$85.3K	3.5%
7	GREECE	$82.3K	3.4%
8	TUNISIA	$76.1K	3.1%
9	ALGERIA	$73.8K	3.0%
10	MOROCCO	$71.7K	2.9%

CAMBODIA is India's largest mefloquine export destination, absorbing 49.2% of total exports worth $1.2M. The top 5 importing countries — CAMBODIA, BRAZIL, NEPAL, UGANDA, SINGAPORE — together account for 65.3% of India's total mefloquine export value. The remaining 51 destination countries collectively receive the other 34.7%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Mefloquine to India?

1 origin countries · Total import value: $96

India imports mefloquine from 1 countries with a combined import value of $96. The largest supplier is CANADA ($96, 13 shipments), followed by . All values are from Indian Customs (DGFT) import records.

Countries Supplying Mefloquine to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	CANADA	$96	13	100.0%

CANADA is the largest supplier of mefloquine to India, accounting for 100.0% of total import value. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Mefloquine

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

As of March 2026, the FDA's Orange Book does not list any approved Abbreviated New Drug Applications (ANDAs) for mefloquine, indicating a lack of generic competition in the U.S. market. Mefloquine was designated as an orphan drug on July 22, 1987, for the treatment and prevention of chloroquine-resistant *Plasmodium falciparum* malaria; however, it has not received FDA approval for this indication.

Given the absence of approved ANDAs, Indian exporters aiming to enter the U.S. market must pursue the New Drug Application (NDA) pathway, which involves comprehensive clinical trials and a rigorous review process. The current exporter count from India suggests a competitive landscape, yet the U.S. market remains untapped due to regulatory barriers.

2EU & UK Regulatory Framework

In the European Union, mefloquine is authorized for the treatment and prevention of malaria. The European Medicines Agency (EMA) conducted a Periodic Safety Update Report Single Assessment (PSUSA) for mefloquine, resulting in a variation to its marketing authorization in January 2018. (ema.europa.eu) The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has issued strengthened warnings regarding neuropsychiatric side effects associated with mefloquine, advising against its use in individuals with a history of psychiatric disorders. (gov.uk)

Compliance with EU Good Manufacturing Practice (GMP) standards is mandatory for exporters targeting these markets. This includes adherence to stringent quality control measures and regular inspections to ensure product safety and efficacy.

3WHO Essential Medicines & Global Standards

Mefloquine is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in global malaria treatment protocols. It is also listed in various pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality specifications across different regions.

4India Regulatory Classification

In India, mefloquine is classified under Schedule H of the Drugs and Cosmetics Act, requiring a prescription for its dispensation. The National Pharmaceutical Pricing Authority (NPPA) has not set a ceiling price for mefloquine, allowing market-driven pricing. Exporters must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for the export of pharmaceuticals, ensuring compliance with national regulations.

5Patent & Exclusivity Status

The primary patents for mefloquine have expired, leading to the availability of generic versions in various markets. However, the absence of approved ANDAs in the U.S. indicates limited generic competition in that market.

6Recent Industry Developments

In December 2025, the EMA updated the product information for mefloquine-containing medicines, emphasizing the need for monitoring neuropsychiatric side effects. (ema.europa.eu) In November 2025, the UK Ministry of Defence reported a continued decline in mefloquine prescriptions among armed forces personnel, reflecting a shift towards alternative antimalarial therapies. (gov.uk)

These developments highlight the evolving regulatory landscape and the importance of staying informed about policy changes affecting mefloquine's market dynamics.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Mefloquine

Retail & reference prices across 9 markets vs. India FOB export price of $9.62/unit

Global Price Benchmark for Mefloquine across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$10.00	USD	According to the FDA Orange Book, Mefloquine is an approved antimalarial medication.
United Kingdom	$9.75	GBP	As per the NHS Drug Tariff, Mefloquine is listed for malaria prophylaxis.
Germany	$9.00	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) includes Mefloquine in its list of approved antimalarial drugs.
Australia	$8.40	AUD

Supply Chain Risk Assessment — Mefloquine

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

Mefloquine, an antimalarial medication, is primarily produced in India, which has a robust pharmaceutical manufacturing sector. However, India's production of Active Pharmaceutical Ingredients (APIs) like Mefloquine is heavily reliant on Key Starting Materials (KSMs) imported from China. According to the U.S. Pharmacopeia's Medicine Supply Map, 41% of KSMs used in U.S.-approved APIs are solely sourced from China, while 16% come exclusively from India. This dependency exposes the supply chain to risks associated with geopolitical tensions, trade disputes, and regulatory changes in China.

In recent years, environmental regulations in China have led to the shutdown of several chemical manufacturing plants, causing disruptions in the supply of KSMs. For instance, in July 2018, Chinese authorities enforced stringent pollution controls, resulting in the closure of numerous factories and subsequent supply chain interruptions for Indian pharmaceutical companies. Such events underscore the vulnerability of India's pharmaceutical industry to external factors affecting KSM availability.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that between 2022 and 2026, Mefloquine exports from India totaled $2.4 million USD across 265 shipments, involving 75 active exporters and reaching 56 destination countries. Notably, the top five exporters accounted for 69.4% of the total export value, with CIPLA LIMITED alone contributing 57.3% ($1.4 million USD). This high supplier concentration poses a significant single-source risk; any operational disruptions at CIPLA LIMITED could substantially impact global Mefloquine supply.

Access Complete Mefloquine Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 265 transactions across 56 markets.

Request Demo View Pricing

Frequently Asked Questions — Mefloquine Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top mefloquine exporters from India?

The leading mefloquine exporters from India are CIPLA LIMITED, KALINDI OVERSEAS, YASHICA PHARMACEUTICALS PRIVATE LIMITED, and 4 others. CIPLA LIMITED leads with 57.3% market share ($1.4M). The top 5 suppliers together control 69.4% of total export value.

What is the total export value of mefloquine from India?

The total export value of mefloquine from India is $2.4M, recorded across 265 shipments from 75 active exporters to 56 countries. The average shipment value is $9.2K.

Which countries import mefloquine from India?

India exports mefloquine to 56 countries. The top importing countries are CAMBODIA (49.2%), BRAZIL (4.7%), NEPAL (3.9%), UGANDA (3.9%), SINGAPORE (3.7%), which together account for 65.3% of total export value.

What is the HS code for mefloquine exports from India?

The primary HS code for mefloquine exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Mefloquine

Mefloquine

Top Mefloquine Exporters from India

Top Countries Importing Mefloquine from India

Who Supplies Mefloquine to India?

Quick Facts

Related Antimalarial & Antiparasitic

Related Analysis

Need Details?

Regulatory Landscape — Mefloquine

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Mefloquine

Supply Chain Risk Assessment — Mefloquine

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Mefloquine Trade Intelligence

Frequently Asked Questions — Mefloquine Exports from India

Who are the top mefloquine exporters from India?

What is the total export value of mefloquine from India?

Which countries import mefloquine from India?

What is the HS code for mefloquine exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of mefloquine exports from India?

Which ports handle mefloquine exports from India?

Why is India a leading exporter of mefloquine?

What certifications do Indian mefloquine exporters need?

How many buyers import mefloquine from India?

What is the market share of the top mefloquine exporter from India?

Analysis Methodology